Pediatric Pharmacy Specialty Review Course for Recertification, Core Therapeutic Modules + RECERT EXAMS Package (Cert # L209285)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 09/02/2020
Content Release Date: 09/23/2020
Expiration Date: 09/21/2021
Activity Type: Application-based
CE Credits: 19 (BPS and ACPE)
Activity Fee: $475 (ASHP member); $675 (non-member) 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

Target Audience

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in pediatric pharmacy. 

Activity Overview

This course is intended for BCPPS in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice. The course uses a case-based approach to discuss patient care issues. In this series, faculty will:

  • Review pertinent clinical topics and practice skills
  • List valuable resources for further self-study  

This online course consists of 20 activities (see table below) and provides up to 19 hours of continuing pharmacy education credit and/or recertification credit. 

Recertification Credit*

Board certified pharmacists are eligible to receive up to 19 hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.  You are allowed only one attempt to successfully complete this assessment.

This course is not intended for those preparing to take the BPS Pediatric Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/pediatric-review 

These activities are part of the ASHP professional development program for BCPPS recertification approved by the BPS. 

* Please note: Review Course for Recertification may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. 

Review Course

Learning Activity

ACPE Number

Credit

Hours

*Assessment Pass Point

Complex Case: Deep Vein Thrombosis and Metabolic Syndrome

0204-0000-20-994-H01-P

1.50

84%

Diabetic Ketoacidosis

0204-0000-20-995-H01-P

1.50

Complex Case: Acute Asthma

0204-0000-20-996-H01-P

1.50

Complex Case: Pneumonia and Septic Shock

0204-0000-20-997-H01-P

1.50

 

Group 1 Assessment

6.0

 

Complex Case: Acute Lymphoblastic Leukemia and Supportive Care

0204-0000-20-998-H01-P

1.50

76%

Regulatory and IRB Considerations

0204-0000-20-999-H03-P

0.50

Complex Case: Sickle Cell Disease with Vaso-Occlusive Crisis

0204-0000-20-600-H01-P

1.50

Medication Error and Practice Management

0204-0000-20-601-H05-P

1.50

 

Group 2 Assessment

5.0

 

Complex Case: Neonatal Sepsis

0204-0000-20-602-H01-P

1.50

77%

Statistics, Evidence-Based Medicine, and Clinical Trial Design

0204-0000-18-934-H04-P

2.00

Complex Case: Status Epilepticus and Cardiopulmonary Resuscitation

0204-0000-20-603-H01-P

1.50

Group 3 Assessment

5.0

 

Review Course Learning Objectives

ACPE #:0204-0000-20-994-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including deep vein thrombosis, type 2 diabetes mellitus, dyslipidemia, and hypertension.
• Identify resources and treatment options for sexually transmitted infections.
• Select appropriate monitoring considerations of anticoagulation medications.
• Recognize the impact of pharmacogenomic differences on warfarin therapy.

ACPE #: 0204-0000-20-995-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including diabetic ketoacidosis, type 1 diabetes mellitus, and urinary tract infection.
• Calculate maintenance and replacement fluid requirements and urine output.
• Identify factors affecting medication adherence.
• Recommend appropriate dosing of insulin based on patient age and weight.
• Select an effective method of delivery for insulin.

ACPE #: 0204-0000-20-996-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute and chronic asthma, ADHD, acne and GERD.
• Evaluate essential components of social history, including smoke exposure and home environment.
• Formulate a plan to address barriers to patient education and adherence, including age, language, cultural considerations, and inhaler technique.
• Describe the impact of age on classification and management of asthma.
• Assess available resources to improve access to medications, including patient assistance programs.

ACPE #: 0204-0000-20-997-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including pneumonia, septic shock, and acute kidney injury.
• Calculate creatinine clearance, fluid requirements, and urine output in pediatric patients.
• Apply scoring systems to assess pediatric patients.
• Select appropriate dosing for medications based on renal dysfunction and/or replacement modalities.
• Differentiate vital signs between stable and critically-ill pediatric patients.

ACPE #: 0204-0000-20-998-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute lymphoblastic leukemia (ALL), tumor lysis syndrome, febrile neutropenia, invasive aspergillosis infection, and Clostridium difficile infection.
• Select appropriate medication dose modifications related to hepatic impairment.

ACPE #: 0204-0000-20-999-H03-P
• Identify appropriate off-label use of medications in the pediatric population.
• Recognize IRB requirements for documentation of clinical studies
• List characteristics of patients who require informed assent/consent.
• Recognize federal legislation relevant to the use of medications in pediatric patients.

ACPE #: 0204-0000-20-600-H01-P
• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including a vaso-occlusive crisis, cellulitis, constipation, and need for immunizations.
• Select most appropriate patient controlled analgesia regimen based on vaso-occlusive crisis severity.
• Apply pharmacodynamic principles when selecting appropriate antibiotic regimens.
• Identify required immunizations for adolescents, including patients with risk factors for vaccine-preventable diseases.

ACPE #: 0204-0000-20-601-H05-P
  • Incorporate position statements, white papers, national guidelines from recognized regulatory organizations into institutional policies and procedures related to:
    • Medication reconciliation
    • Appropriate drug preparation and delivery (e.g., extemporaneous compounding and standardized concentrations)
    • Selection of appropriate equipment/technology and decision support.
    • Adverse drug event monitoring and reporting, or
    • Selection of appropriate equipment/technology and decision support.
ACPE #: 0204-0000-20-602-H01-P
  • Develop appropriate treatment and monitoring plans for a complex neonatal patient with multiple conditions, including patent ductus arteriosus, apnea of prematurity, early and late onset sepsis, and necrotizing enterocolitis.
  • Evaluate the clinical and therapeutic implications of placental transfer of medications.
  • Identify age-specific pharmacokinetic differences among neonates, infants, children, and adolescents.
  • Apply FDA alerts for adverse drug events and drug-drug interactions into clinical practice.
  • Identify characteristics that facilitate transfer of medications into the breast milk. 
ACPE #: 0204-0000-18-934-H04-P
  • Determine quality and appropriateness of a study by examining study design, statistical analysis, sources of bias, quality of conclusions, and interpretation of graphs.
  • Determine clinical and statistical significance of a study outcome.
  • Determine whether the study applies to a specified patient population. 
ACPE #: 0204-0000-20-603-H01-P
  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions and needs, including status epilepticus, cardiopulmonary resuscitation, and sedation/analgesia.
  • Differentiate treatment options in cardiopulmonary arrest based upon patient presentation.
  • Select the appropriate dose and route of administration for medications.
  • Assess the need and processes for reporting adverse drug events.
  • Identify cultural considerations related to treatment and counseling of the pediatric population.
  • Distinguish between the four preceptor roles. 

Core Therapeutic Modules

The Core Therapeutic Modules for Recertification Package consists of 3 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).

 

ACPE Number

Learning Module

Credit Hours

*Assessment Pass Point

0204-0000-20-604-H01-P

Select Topics in Pediatric Infectious Diseases Part 2

1.00

72%

0204-0000-20-605-H01-P

Select Topics in Pediatric Nutrition 

1.00

0204-0000-20-606-H01-P

Select Topics in Pediatric Pulmonary Disease: Cystic Fibrosis and Chronic Asthma 

1.00

 

Core Therapeutic Learning Objectives 

ACPE #: 0204-0000-20-604-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with HIV, Herpes Simplex Virus Types 1 and 2, or systemic fungal infections.

ACPE #: 0204-0000-20-605-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Evaluate if nutrition needs of a pediatric patient are being met based on assessment of appropriate growth and development.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with parenteral or enteral nutrition needs.
  • Evaluate patients for weight (overweight or obese) based on current guidelines.
ACPE #: 0204-0000-20-606-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Interpret relevant clinical and laboratory data and results of diagnostic procedures in a pediatric patient with an exacerbation of cystic fibrosis or chronic asthma.
  • Identify relevant differences in laboratory sampling for pediatric patients (e.g., blood volume; method, frequency and timing of sampling).
  • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.

Planners, Presenters and Reviewers

View Faculty bios

Faculty

Advanced Clinical Pharmacist
Primary Children's Hospital
Salt Lake City, Utah 
Associate Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Clinical Pharmacy Specialist--Pediatric Critical Care
The Children's Hospital at OU Medical Center
Oklahoma City, Oklahoma 
Clinical Pharmacist - Pediatric Ambulatory Care
University of Virginia Children’s Hospital
Charlottesville, Virginia 
Clinical Associate Professor
Rutgers University
Piscataway, New Jersey
Pediatric Pharmacist
Saint Barnabas Medical Center
Livingston, New Jersey 
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma 
Professor and Chair
University of Maryland School of Pharmacy
Baltimore, Maryland 
Associate Professor of Pharmacy Practice
Butler University College of Pharmacy and Health Sciences
Indianapolis, Indiana 
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York 
Assistant Director, Pharmacy Services
UF Health Shands Hospital
Gainesville, Florida 
Pediatric Hematology Oncology Pharmacist
Children's of Alabama
Birmingham, Alabama 

Content Matter Experts

Associate Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Clinical Pharmacy Specialist--Pediatric Critical Care
The Children's Hospital at OU Medical Center
Oklahoma City, Oklahoma 
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York

Reviewers

Michelle Abalos, Pharm.D.
Kristi Hofer, Pharm.D. 

Meghan Baldo, Pharm.D., BCPPS
Jessica Biggs, Pharm.D., BCPPS
Karen Brodbeck, BCPPS
Kelly Burch, Pharm.D., BCPPS
Mary Petrea Cober, Pharm.D., BCNSP, BCPPS, FASPEN
Debra Determan, Pharm.D., BCPPS
Stephanie Duehlmeyer, Pharm.D., BCPPS
Alexandra Fife, Pharm.D., BCPPS
Elizabeth Forster, Pharm.D., BCPPS
Jessica Frye, Pharm.D., BCPPS
Carina Fung, Pharm.D., BCPPS
Karen Gradischer, Pharm.D., BCPPS
Aaron Harthan, Pharm.D., BCPPS
Margaret Heger, Pharm.D., BCPS, BCPPS
Alyssa Hobby, Pharm.D., BCPPS
Amy Holmes, Pharm.D., BCPPS
Harlan Husted, Pharm.D, M.B.A., BCPS, BCPPS
David Hutchinson, Pharm.D., BCPS, BCPPS
Jenna Kaplan, Pharm.D., BCPPS
Katelin Kimler, Pharm.D., BCPPS
Jason Koury, Pharm.D., BSN
Megan Kroll, Pharm.D., BCPPS, CNSC
Ekaterina Kurdyukova, Pharm.D., BCPPS
Emily Kurzen, Pharm.D., BCPPS
Dennis LaChance, Pharm.D., BCPPS
Biljana Lanier, BSPharm, BCPPS
Lindsey Lepard, Pharm.D., BCPPS
Jordyn Metcalf, Pharm.D., BCPS
Julie Miller, Pharm.D., BCPPS
Ashley Nebbia, Pharm.D., BCPPS
Hong (Rose) Nguyen, Pharm.D., BCPPS
Lane Nguyen, Pharm.D., BCPPS
Valerie Nolt, Pharm.D., BCPPS
Emi Onuki, Pharm.D., BCPPS
Leslie Patatanian, B.S., Pharm.D., BCPPS
Karla Resendiz, Pharm.D. BCPPS
Marie Rossique-Gonzalez, Pharm.D. BCPPS
Emily Rowe, Pharm.D., M.S., BCPPS, BCPS
Alicia Sanchez, Pharm.D., BCPPS
Dimitri Savva, Pharm.D., BCPPS
Anna Simmont, Pharm.D., BCPS, BCPPS
Julie Slomkowski, Pharm.D., BCPS, BCPPS
Tara Smith, Pharm D, BCPPS
Shannon Song, Pharm.D., BCPPS
Britta Taylor, Pharm.D.,BCPPS
Susan Villegas, Pharm.D., BCPPS
Britany Walls, Pharm.D., BCPPS
Anthony Zacheretti, Pharm.D., BCPPS

Faculty

Clinical Pharmacist, Department of Pediatrics
OU College of Medicine
Oklahoma City, Oklahoma
Pediatric Pharmacy Clinical Specialist
University of Missouri Healthcare
Women's and Children's Hospital
Columbia, Missouri
Associate Professor
University of Oklahoma
College of Pharmacy
Oklahoma City, Oklahoma

Content Matter Experts

Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York

Reviewers

Michelle Abalos, Pharm.D.
Kristi Hofer, Pharm.D.

Renad Abu-Sawwa, Pharm.D., BCPPS
Michelle Barrett, Pharm.D., BCPS
Michelle Barrie, Pharm.D., BCPPS
Monica Bogenschutz, Pharm.D., BCPS, BCPPS
Patricia Christoff, R.Ph., Pharm.D., BCPPS, BCIDP
Melissa Cook, Pharm.D., BCPPS
Brienne Costigan, Pharm.D., BCPPS
Stephanie Duehlmeyer, Pharm.D., BCPPS
Reid Grobe, Pharm.D., BCPPS
Sarah Hale, Pharm.D., BCPPS
Kaitlin Hughes, Pharm.D., BCPPS
Melissa Johnson, Pharm.D., BCPPS
Sarah Kubes, Pharm.D., BCPPS
Sarah Newman, Pharm.D., BCPS, BCPPS
Nicole Phillips, Pharm.D., BCPPS
Stephanie Ramirez Irrobali, Pharm.D., BCPPS
Michael Raschka, Pharm.D., BCPPS

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

  • Jennifer L. Thackray: Employer, Equashield; Consultant, Wolters Kluwer 

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity. 

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites. 

View the minimum technical and system requirements for learning activities. 

Development

These activities were developed by ASHP.